DCF — TRINITY MEDICAL
Enterprise Value: $-35.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-35.1M
Enterprise Value
$-11.2M
PV of Cash Flows
$-23.9M
PV of Terminal Value
$-38.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $25.4M | $-2.1M | -8.0% | $-3.2M | $-2.9M |
| Year 2 | $26.1M | $-1.9M | -7.0% | $-3.0M | $-2.5M |
| Year 3 | $26.9M | $-1.7M | -6.0% | $-2.9M | $-2.1M |
| Year 4 | $27.7M | $-1.6M | -6.0% | $-2.8M | $-1.9M |
| Year 5 | $28.6M | $-1.6M | -6.0% | $-2.8M | $-1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-35.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$24.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.08865512592185675
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5